Adimmune Corp (4142) — Capital Reinvestment Ratio
Latest as of December 2024:
0.06x
Adimmune Corp (4142) has a Capital Reinvestment Ratio of 0.06x as of December 2024, meaning it reinvests 0% of its operating cash flow (NT$658.32 Million) in capital expenditures (NT$42.60 Million). See 4142 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.06x
Capex / Operating Cash Flow
Operating Cash Flow
NT$658.32 Million
TWD
Capital Expenditures
NT$42.60 Million
TWD
Data as of
Dec 2024
Most recent filing
Adimmune Corp Capital Reinvestment Ratio (2007–2024)
This chart tracks Adimmune Corp's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Adimmune Corp (2007–2024)
Year-by-year Capital Reinvestment Ratio for Adimmune Corp from 2007 to 2024. For live market cap and broader valuation context, see 4142 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.23x | NT$668.48 Million | NT$155.22 Million | ▲ +147.0% |
| 2020 | 0.09x | NT$2.32 Billion | NT$218.30 Million | ▼ -94.3% |
| 2017 | 1.65x | NT$6.87 Million | NT$11.35 Million | ▲ +36.1% |
| 2010 | 1.21x | NT$516.39 Million | NT$626.30 Million | ▲ +3.5% |
| 2009 | 1.17x | NT$600.42 Million | NT$703.82 Million | ▼ -86.2% |
| 2007 | 8.50x | NT$31.26 Million | NT$265.77 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow